Mastek Ltd (MASTEK) Q2FY27 Concall Summary - Sep-2026 Qtr
Key Takeaways
- Management aims for a medium-term EBITDA margin recovery of at least 160 basis points, despite near-term pressure from salary hikes and rising onshoring costs in the UK.
- A delay in a large US federal deal and slower UK project consumption caused a 7.7% sequential dip in the 12-month order backlog, right-shifting revenue expectations.
- The pipeline for large deals over $100 million is growing phenomenally, with a major UK NHS contract renewal and expansion opportunity expected in H2.
Performance Overview
- Delivered healthy revenue growth of 2.4% quarter-on-quarter in constant currency, reaching $107.3 million.
- Experienced softness in the 12-month order backlog, which declined 7.7% sequentially, due to project start delays and slower consumption.
- Strengthened the strategic pivot to an AI-native organization, with over 40% of new deals being AI-related, covering transformation, productivity, and foundation services.
- The UK geography showed robust performance with 4.1% revenue growth, driven by a 16% expansion in the Financial Services sub-sector.
- North America business continues to show strong deal momentum with its total order backlog growing over 50% year-on-year.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.
Tone & Disclosure
Log in to Stocksigma to read the Tone & Disclosure section of this summary.